Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer. - Liu, Dongze; Qin, Zheng; Yi, Bocun; Xie, Hongbo; Liang, Yunan; Zhu, Liang; Yang, Kuo; Xu, Yong; Zhang, Hongtuan (Cancer Cell International, 2024)